Reduced responsiveness of blood leukocytes to lipopolysaccharide does not predict nosocomial infections in critically ill patients

Shock

Volumn 44, Issue 2, 2015, Pages 110-114

  Van Vught, Lonneke A ^a   Wiewel, Maryse A ^a   Hoogendijk, Arie J ^a   Scicluna, Brendon P ^a   Belkasim Bohoudi, Hakima ^a   Horn, Janneke ^b   Schultz, Marcus J ^b   Van Der Poll, Tom ^a,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Department of Intensive Care ^*  (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Critically ill; Immunosuppression; Intensive care unit; Nosocomial infection; Whole blood stimulation

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ABDOMINAL INFECTION; ADULT; AGED; ARTICLE; CATHETER INFECTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EX VIVO STUDY; EYE INFECTION; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE; LEUKOCYTE COUNT; MALE; MENINGITIS; PNEUMONIA; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SKIN INFECTION; SUPERNATANT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WOUND INFECTION; BLOOD; CASE CONTROL STUDY; CRITICAL ILLNESS; CROSS INFECTION; DRUG EFFECTS; IMMUNE SYSTEM; MIDDLE AGED; PROSPECTIVE STUDY;

AGED; CASE-CONTROL STUDIES; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HUMANS; IMMUNE SYSTEM; INTENSIVE CARE UNITS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84942606400     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000391     Document Type: Article

References (15)

1. Vincent JL: Nosocomial infections in adult intensive-care units. Lancet 361:2068-2077, 2003.
2. Deutschman CS, Tracey KJ: Sepsis: current dogma and new perspectives. Immunity 40:463-475, 2014.
3. Adib-Conquy M, Cavaillon JM: Compensatory anti-inflammatory response syndrome. Thromb Haemost 101:36-47, 2009.
4. Hotchkiss RS, Monneret G, Payen D: Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862-874, 2013.
5. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, et al.: A genomic storm in critically injured humans. J Exp Med 208:2581-2590, 2011.
6. Monneret G, Venet F, Pachot A, Lepape A: Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 14:64-78, 2008.
7. Duffy D, Rouilly V, Libri V, Hasan M, Beitz B, David M, Urrutia A, Bisiaux A, Labrie ST, Dubois A, et al. Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli. Immunity 40:436-450, 2014.
8. Klein Klouwenberg PM, Ong DS, Bos LD, de Beer FM, van Hooijdonk RT, Huson MA, Straat M, van Vught LA, Wieske L, Horn J, et al. Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med 41:2373-2378, 2013.
9. Klein Klouwenberg PM, van Mourik MS, Ong DS, Horn J, Schultz MJ, Cremer OL, Bonten MJ, MARS Consortium: Electronic implementation of a novel surveillance paradigm for ventilator-Associated events. Feasibility and validation. Am J Respir Crit Care Med 189:947-955, 2014.
10. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128-140, 1988.
12. Calandra T, Cohen J, International Sepsis Forum Definition of Infection in the ICU Consensus Conference: The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33:1538-1548, 2005.
13. Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, Malcus C, Chéron A, Allaouchiche B, Gueyffier F, et al. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care 15:R99, 2011.
14. Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohé J, Vanhems P, Monneret G: Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859-1866, 2010.
15. Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Volk HD, Carcillo JA: Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 37:525-532, 2011.